Prestige Consumer Healthcare (PBH) Assets Growth (1y) (2012 - 2025)
Prestige Consumer Healthcare (PBH) Assets Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.96% |
| Sep 30, 2025 | 3.78% |
| Jun 30, 2025 | 3.75% |
| Mar 31, 2025 | 2.53% |
| Dec 31, 2024 | -0.31% |
| Sep 30, 2024 | -0.48% |
| Jun 30, 2024 | -1.14% |
| Mar 31, 2024 | -1.05% |
| Dec 31, 2023 | -10.93% |
| Sep 30, 2023 | -9.40% |
| Jun 30, 2023 | -9.14% |
| Mar 31, 2023 | -8.63% |
| Dec 31, 2022 | 2.47% |
| Sep 30, 2022 | 0.07% |
| Jun 30, 2022 | 3.46% |
| Mar 31, 2022 | 7.04% |
| Dec 31, 2021 | 5.50% |
| Sep 30, 2021 | 7.03% |
| Jun 30, 2021 | 3.16% |
| Mar 31, 2021 | -2.41% |